Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Welchol in Type 2 Diabetes Mellitus
NCT00951899Phase 4
Key facts
- Status
- Completed
- Start
- Aug 2009
- Primary completion
- Jul 2012
- Countries
- 1
- Sponsor
- Mayo Clinic
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Drugs
- colesevelam
- Conditions
- type 2 diabetes mellitus (T2DM)
01
Overview
Phase 4, randomised, double-blind trial of colesevelam in type 2 diabetes mellitus (T2DM), sponsored by Mayo Clinic. Started Aug 2009; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Registry description
The goal of this study was to determine the metabolic mechanism for a certain type medication's ability to lower blood sugar after a meal in Type 2 Diabetics, in order to develop a better understanding of it's potential role in the treatment of obesity.
Beyond the preview
Go deeper on NCT00951899.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00951899.